KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $3.3 million.

  • Biolife Solutions' Capital Expenditures rose 19640.93% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 7359.26%. This contributed to the annual value of $3.2 million for FY2024, which is 4942.8% down from last year.
  • According to the latest figures from Q3 2025, Biolife Solutions' Capital Expenditures is $3.3 million, which was up 19640.93% from $1.4 million recorded in Q2 2025.
  • Biolife Solutions' 5-year Capital Expenditures high stood at $4.4 million for Q4 2022, and its period low was $356000.0 during Q1 2024.
  • Moreover, its 5-year median value for Capital Expenditures was $1.5 million (2023), whereas its average is $1.8 million.
  • In the last 5 years, Biolife Solutions' Capital Expenditures skyrocketed by 245904.76% in 2021 and then tumbled by 8919.58% in 2024.
  • Quarter analysis of 5 years shows Biolife Solutions' Capital Expenditures stood at $1.6 million in 2021, then soared by 184.04% to $4.4 million in 2022, then plummeted by 77.95% to $981000.0 in 2023, then dropped by 22.32% to $762000.0 in 2024, then soared by 333.33% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q3 2025, $1.4 million for Q2 2025, and $552000.0 during Q1 2025.